OB:BRGChemicals
Borregaard (OB:BRG) On Higher BioMaterials Guidance And A Fair Value Debate
Borregaard (OB:BRG) is back in focus after its second quarter 2026 report showed higher sales alongside a shift to a net loss, followed by updated volume guidance that raised expectations for the BioMaterials segment.
See our latest analysis for Borregaard.
Borregaard’s recent guidance on higher BioMaterials volumes has come alongside a 6.05% 1 month share price return and a year to date share price decline of 19.74%. The 5 year total shareholder return is also down, which suggests momentum...